“…In the past decades, different studies underlined the existence of clinical and serological differences between patients with EORA and those with YORA [145,148,151]. In contrast with YORA, which mainly occurs in women, in EORA, a balanced gender distribution has been reported, with evidence of a clinical course characterized by important systemic features, higher disease activity, and more pronounced inflammatory parameters [145,148,151]. Also, compared to YORA, EORA shows more common involvement of large joints 145, 148, 151], and a higher frequency of distalproximal involvement seems characteristic [150].…”